Guardion Health Sciences Inc Share Price Nasdaq
Equities
US40145Q2030
Pharmaceuticals
Sales 2022 | 11.05M 918M | Sales 2023 | 12.25M 1.02B | Capitalization | 6.81M 566M |
---|---|---|---|---|---|
Net income 2022 | -14M -1.16B | Net income 2023 | - 0 | EV / Sales 2022 | -0.16 x |
Net cash position 2022 | 10.65M 885M | Net cash position 2023 | 6.36M 528M | EV / Sales 2023 | 0.04 x |
P/E ratio 2022 |
-0.51
x | P/E ratio 2023 |
42.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 79.71% |
Managers | Title | Age | Since |
---|---|---|---|
Jan Hall
CEO | Chief Executive Officer | - | 19/23/19 |
Chairman | 72 | 30/15/30 | |
Katie Cox
AUD | Comptroller/Controller/Auditor | - | 25/23/25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 30/15/30 | |
Mark Goldstone
BRD | Director/Board Member | 60 | 01/15/01 |
Donald Gagliano
BRD | Director/Board Member | 71 | 09/19/09 |
1st Jan change | Capi. | |
---|---|---|
+42.41% | 739B | |
+32.34% | 598B | |
-5.80% | 353B | |
+17.33% | 318B | |
+3.41% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.04% | 164B |